Acorah Software Products - Accounts Production 19.4.351 false true false true No description of principal activity 1 March 2025 28 February 2026 28 February 2026 16227096 Dr. Morvarid Saeinasab iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16227096 2025-02-28 16227096 2026-02-28 16227096 2025-03-01 2026-02-28 16227096 frs-core:CurrentFinancialInstruments 2026-02-28 16227096 frs-bus:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 16227096 frs-bus:FilletedAccounts 2025-03-01 2026-02-28 16227096 frs-bus:Micro-entities 2025-03-01 2026-02-28 16227096 frs-bus:AuditExempt-NoAccountantsReport 2025-03-01 2026-02-28 16227096 frs-bus:Director1 2025-03-01 2026-02-28
Registered number: 16227096
Espinas Clinic Ltd
Unaudited Financial Statements
For The Year Ended 28 February 2026
Balance Sheet
Registered number: 16227096
2026
£
Fixed assets 6,046
Current assets 137
Creditors: Amounts Falling Due Within One Year (26 )
NET CURRENT ASSETS 111
TOTAL ASSETS LESS CURRENT LIABILITIES 6,157
NET ASSETS 6,157
CAPITAL AND RESERVES 6,157

Notes

1. General Information
Espinas Clinic Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16227096 . The registered office is Suite S60 Cheadle Place, Stockport Road, Cheadle, SK8 2JX.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr. Morvarid Saeinasab
Director
13/10/2026